Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

Forbes logo
Diversity Drives Better Outcomes
Read
Psychiatric Times
New Social Anxiety Disorder Drug Differentiates Mechanism of Action
Read
Pharmacy Times
Expert: There is a Dire Need to Improve, More Effectively Treat Mental Health Disorders for Returning Veterans
Read
Nasdaq
This Drug Has the Potential to Become the First FDA-Approved on-Demand Treatment for Social Anxiety
Read
Business Insider logo image
Psychiatric drugs were once a $30 billion business. Analysts say these 9 companies could revive it.
Read
image thumbnail (1)
Karyopharm taps long­time Pfiz­er, Am­gen vet to steer the ship; With Mer­ck in the rearview mir­ror, Roger Perl­mut­ter stakes his claim to a CEO job — and it's a sur­pris­ing choice
Read
image thumbnail
BioSpace Movers & Shakers, May 7
Read
image thumbnail
Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery
Read
BioWorld logo image.png
To read the full story, subscribe or sign in. Appointments and advancements for May 4, 2021
Read